Biotechnology Stocks
| # | Últimos 7 dias | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2697 |  PHAT Phathom Pharmaceuticals, Inc. - Common Stock | 8.62 USD | -2.82% | -8.69% | -25.69% | -27.87% | 697.37 M USD | ||
| 2699 |  CTMX CytomX Therapeutics, Inc. - Common Stock | 3.20 USD | -2.44% | -5.60% | -1.54% | +50.23% | 697.28 M USD | ||
| 2707 |  RGNX REGENXBIO Inc. - Common Stock | 8.14 USD | -24.07% | -24.56% | -19.00% | -39.39% | 537.35 M USD | ||
| 2709 |  ZVRA Zevra Therapeutics, Inc. - Common Stock | 11.59 USD | -2.36% | +2.20% | +21.74% | +8.93% | 688.26 M USD | ||
| 2712 |  ASMB Assembly Biosciences, Inc. - Common Stock | 33.83 USD | -1.60% | +4.64% | +31.12% | +14.95% | 688.80 M USD | ||
| 2757 |  HELP Cybin Inc. - Common Stock | 12.28 USD | -2.46% | +5.95% | +57.03% | +36.90% | 634.04 M USD | ||
| 2764 |  AUTL Autolus Therapeutics plc - American Depositary Shares | 2.33 USD | -3.32% | +5.91% | +59.59% | +32.39% | 620.16 M USD | ||
| 2765 |  CRMD CorMedix Inc. - Common Stock | 8.26 USD | +0.73% | +9.40% | +3.38% | -26.90% | 643.82 M USD | ||
| 2768 |  SGMT Sagimet Biosciences Inc. - Series A Common Stock | 10.02 USD | -2.24% | -6.09% | +40.73% | +39.17% | 622.83 M USD | ||
| 2777 |  MDXG MiMedx Group, Inc - Common Stock | 4.37 USD | +0.92% | +3.31% | +3.07% | -39.89% | 636.97 M USD | ||
| 2785 |  SLN Silence Therapeutics Plc - American Depository Share | 13.22 USD | -0.38% | -4.06% | +18.78% | +169.25% | 624.60 M USD | ||
| 2789 |  VSTM Verastem, Inc. - Common Stock | 6.67 USD | -3.19% | +1.37% | +8.99% | -26.54% | 604.06 M USD | ||
| 2797 |  PRME Prime Medicine, Inc. - Common Stock | 3.23 USD | -4.72% | +5.56% | +8.75% | -9.78% | 585.85 M USD | ||
| 2799 |  ARVN Arvinas, Inc. - Common Stock | 9.09 USD | -2.99% | +0.44% | +11.81% | -2.26% | 594.36 M USD | ||
| 2805 |  ALT Altimmune, Inc. - Common Stock | 3.06 USD | -1.61% | +2.34% | +8.90% | -13.31% | 595.22 M USD | ||
| 2809 |  VALN Valneva SE - American Depositary Shares | 6.60 USD | -5.17% | -7.43% | +32.80% | -27.63% | 572.68 M USD | ||
| 2831 |  DRUG Bright Minds Biosciences Inc. - common stock | 75.00 USD | -3.13% | -2.15% | +5.75% | +69.76% | 572.68 M USD | ||
| 2856 |  ZURA Zura Bio Limited - Class A Ordinary shares | 5.80 USD | -0.85% | +3.39% | +9.85% | +185.71% | 555.81 M USD | ||
| 2857 |  ENTX Entera Bio Ltd. - Ordinary Shares | 3.26 USD | +0.93% | +10.88% | +12.03% | +72.49% | 564.44 M USD | ||
| 2870 |  SPRY ARS Pharmaceuticals, Inc. - Common Stock | 5.24 USD | -4.90% | -9.50% | -12.67% | -43.11% | 521.10 M USD |
Notícias Biotechnology Stocks
Dinamarca - Ações fecharam o pregão em alta e o Índice OMX Copenhagen 20 avançou 0,41%
Deutsche Bank rebaixa argenx para neutro após valorização expressiva
Por que as ações da Monte Rosa Therapeutics estão caindo hoje?
Ações da Biomea Fusion disparam com conclusão de inscrições em estudo sobre diabetes
Ações da Monte Rosa caem com início de estudo de fase 2 contra câncer de próstata
Ação da Crinetics Pharmaceuticals atinge máxima histórica de US$ 84,80
H.C. Wainwright reitera recomendação para Biomea Fusion após conclusão de recrutamento em ensaio clínico
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
 OABIW OmniAb, Inc. - Warrant | 0.2339 | +37.59% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
 BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
Losers Biotechnology Stocks
 HUMAW Humacyte, Inc. - Warrant | 0.0050 | -44.44% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
 YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |
 SNTI Senti Biosciences, Inc. - Common Stock | 0.35 | -10.26% |